Vericel Corporation Company Profile
Biologic Drugs for Vericel Corporation
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Vericel Corporation | CARTICEL SM SERVICE | autologous cultured chondrocytes | Injection | 103661 | 4,846,835 | 2007-06-15 | Patent claims search |
| Vericel Corporation | CARTICEL SM SERVICE | autologous cultured chondrocytes | Injection | 103661 | 6,355,006 | 2019-11-09 | Patent claims search |
| Vericel Corporation | CARTICEL SM SERVICE | autologous cultured chondrocytes | Injection | 103661 | 7,108,663 | 2021-12-20 | Patent claims search |
| Vericel Corporation | MACI | autologous cultured chondrocytes on porcine collagen membrane | Cell Sheets | 125603 | 10,011,811 | 2033-11-25 | DrugPatentWatch analysis and company disclosures |
| Vericel Corporation | MACI | autologous cultured chondrocytes on porcine collagen membrane | Cell Sheets | 125603 | 10,016,338 | 2036-12-20 | Patent claims search |
| Vericel Corporation | MACI | autologous cultured chondrocytes on porcine collagen membrane | Cell Sheets | 125603 | 10,239,927 | 2037-07-26 | Patent claims search |
| Vericel Corporation | MACI | autologous cultured chondrocytes on porcine collagen membrane | Cell Sheets | 125603 | 10,328,126 | 2037-03-13 | Patent claims search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
